tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Leuchten, 28 are a HOLD (60.87%), 13 are a BUY (28.26%), 5 are a SELL (10.87%).
Analyst Michael Leuchten, currently employed at JEFFERIES, carries an average stock price target met ratio of 64.29% that have a potential upside of 24.28% achieved within 305 days. Previously, Michael Leuchten worked at UBS, BARCLAYS, TD COWEN.
Michael Leuchten’s has documented 78 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 27-Oct-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/28/2022. The price target of $49.35 was fulfilled within 1 day with a profit of $0.6 (1.23%) receiving and performance score of 12.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$105
$-83.41 (-44.27%)
$95
9 months 26 days ago
(09-Dec-2025)
0/13 (0%)
$-72.77 (-40.93%)
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
10 months 10 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
11 months 8 days ago
(27-Oct-2025)
3/6 (50%)
$14.33 (11.16%)
782
Buy Since 30-May-2024
$97
1 years 6 months 5 days ago
(30-Mar-2025)
0/2 (0%)
$-43.8 (-31.11%)
Hold Since 12-Feb-2025
1 years 7 months 23 days ago
(12-Feb-2025)
7/11 (63.64%)
$120.33 (100.53%)
675
What Year was the first public recommendation made by Michael Leuchten?
